These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19444308)

  • 1. A molecular trio in relapse and remission in multiple sclerosis.
    Steinman L
    Nat Rev Immunol; 2009 Jun; 9(6):440-7. PubMed ID: 19444308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
    Abdin AA; Hasby EA
    Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.
    Boggio E; Dianzani C; Gigliotti CL; Soluri MF; Clemente N; Cappellano G; Toth E; Raineri D; Ferrara B; Comi C; Dianzani U; Chiocchetti A
    J Immunol Res; 2016; 2016():9345495. PubMed ID: 27478856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis.
    Jain P; Coisne C; Enzmann G; Rottapel R; Engelhardt B
    J Immunol; 2010 Jun; 184(12):7196-206. PubMed ID: 20483748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE; Vanderlugt CL; Nickerson-Nutter C; Cornebise M; Scott DM; Perper SJ; Whalley ET; Miller SD
    Blood; 2003 Dec; 102(13):4464-71. PubMed ID: 12933585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory disease: assault on the guardian.
    Ransohoff RM
    Nature; 2007 Jul; 448(7152):421-2. PubMed ID: 17653181
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
    Quach QL; Metz LM; Thomas JC; Rothbard JB; Steinman L; Ousman SS
    Mult Scler; 2013 Dec; 19(14):1867-77. PubMed ID: 23736536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
    Karandikar NJ; Eagar TN; Vanderlugt CL; Bluestone JA; Miller SD
    J Neuroimmunol; 2000 Sep; 109(2):173-80. PubMed ID: 10996219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of relapse and remission in multiple sclerosis.
    Steinman L
    Annu Rev Immunol; 2014; 32():257-81. PubMed ID: 24438352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic.
    Wang C; Chou YK; Rich CM; Link JM; Afentoulis ME; van Noort JM; Wawrousek EF; Offner H; Vandenbark AA
    J Neuroimmunol; 2006 Jul; 176(1-2):51-62. PubMed ID: 16844233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
    Moretti FA; Moser M; Lyck R; Abadier M; Ruppert R; Engelhardt B; Fässler R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17005-10. PubMed ID: 24089451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
    Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
    J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.
    Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S
    Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS.
    Verbeek R; van Dongen H; Wawrousek EF; Amor S; van Noort JM
    Int Immunol; 2007 Mar; 19(3):277-85. PubMed ID: 17267417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonizing the α4β1 integrin, but not α4β7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis.
    Haanstra KG; Hofman SO; Lopes Estêvão DM; Blezer EL; Bauer J; Yang LL; Wyant T; Csizmadia V; 't Hart BA; Fedyk ER
    J Immunol; 2013 Mar; 190(5):1961-73. PubMed ID: 23365083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells.
    Hur EM; Youssef S; Haws ME; Zhang SY; Sobel RA; Steinman L
    Nat Immunol; 2007 Jan; 8(1):74-83. PubMed ID: 17143274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
    Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
    J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.